SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-043371
Filing Date
2021-02-16
Accepted
2021-02-16 07:30:58
Documents
2
Group Members
VERSANT AFFILIATES FUND V, L.PVERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURES V (CANADA), L.P.VERSANT VENTURES V GP-GP (CANADA), I

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d58125dsc13ga.htm SC 13G/A 178046
2 EX-99.1 d58125dex991.htm EX-99.1 21571
  Complete submission text file 0001193125-21-043371.txt   201587
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-7877
Versant Venture Capital V, L.P. (Filed by) CIK: 0001589097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Subject) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90655 | Film No.: 21632447
SIC: 2836 Biological Products, (No Diagnostic Substances)